MTOR and cancer: Furthermore, due to the ability to provide numerous different metabolites, it is well conceivable that autophagy can mitigate the antitumor effects of many different types of metabolic perturbation, so that that the observed vulnerability of drug-resistant cancer cells with mTOR-induced autophagy defects might not be restricted to compounds targeting glycolysis, PDHK or OXPHOS.